Meanwhile, in both cortex of MS patients and healthy controls, IL-33 was found to be expressed by neurones, astrocytes, microglia, and oligodendrocytes while ST2 was expressed by oligodendrocytes and damaged axons [17]. Here, IL1RL1 is linked to myeloid sarcoma.